| Trial ID: | L0074 |
| Source ID: | NCT01029002
|
| Associated Drug: |
Vitamin D
|
| Title: |
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT01029002/results
|
| Conditions: |
Chronic Renal Insufficiency|Proteinuria
|
| Interventions: |
DRUG: Vitamin D|OTHER: Placebo
|
| Outcome Measures: |
Primary: Effect of Vitamin D Supplementation on Albuminuria in CKD Patients as Assessed by Urine Albumin/Creatinine Measures., Urine albumin and creatinine were measured on spot urine specimens., 3 months | Secondary: Effect of Repletion Doses of Vitamin D Increase 25(OH) Vitamin D Levels to Above 30 ng/mL in a Multi-ethnic Sample of Patients With CKD as a Secondary Outcome., 25(OH) vitamin D levels were measured using liquid chromatography., 3 months|Effect of Vitamin D Supplementation on Mean Systolic Blood Pressure as Measured by Ambulatory Blood Pressure in CKD Patients as a Secondary Outcome., 3 months
|
| Sponsor/Collaborators: |
Sponsor: Albert Einstein College of Medicine | Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
74
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2009-10
|
| Completion Date: |
2014-06
|
| Results First Posted: |
2023-08-16
|
| Last Update Posted: |
2023-08-16
|
| Locations: |
Montefiore medical center, Bronx, New York, 10467, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT01029002
|
